Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-24 @ 7:32 PM
NCT ID:
NCT02950103
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven advanced solid tumor patients (recurrent or metastatic), not amenable to curative therapy. Patients must have progressed to standard treatment proven to prolong survival or no standard treatment exists. Tumor types include head and neck squamous cell carcinoma, non-small cell lung cancer, colorectal adenocarcinoma, breast cancer, cervix cancer, prostate cancer, melanoma, pancreas adenocarcinoma, gastric adenocarcinoma, hepatocellular carcinoma
* No concurrent active systemic treatment
* Measurable disease by RECIST v1.1
* Clinical or radiological progression in the last three months
* Eastern Cooperative Oncology Group Performance Status 0-1
* Ability to consent
* Adequate organ function
* Life expectancy greater than 12 weeks
* Ability to swallow
* No previous malignancy in the last 5 years
Exclusion Criteria:
* Pregnancy
* Corticosteroid therapy for prostate cancer
* Uncontrolled comorbidity
* Known hepatitis B, C and HIV
* Central nervous system involvement, except if controlled symptoms and without corticosteroids
* Previous use of phosphoethalonamine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02950103
Study Brief:
Protocol Section:
NCT02950103